At the news
? NEUTRALIMPACT 3/10 8-K filed Jun 11, 2026 at 17:00 ET
Shuttle Pharmaceuticals filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of its common stock, effective June 11, 2026. The split was approved by shareholders on May 21, 2026, and authorized by the board on June 1, 2026. This is a routine capital structure adjustment with no change to the company's market capitalization, authorized shares, or underlying business fundamentals.
- Reverse stock split at a 1:10 ratio, effective June 11, 2026
- Approved by stockholders at the 2026 annual meeting on May 21, 2026
- Board approved the split on June 1, 2026
- No fractional shares issued, holders of fractional shares receive one full post-split share
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access